In the context of AD, the IL‐13–ΔNp63 axis modulated some AD‐related barrier and inflammatory molecules, although further investigation for direct effect of ΔNp63 upregulation on these molecules after IL‐13 treatment is still required. This evidence concerns the gene IL13 and Alzheimer disease.